{
  "docId": "019de511-70b9-744d-9fdd-cb0d25e1c298",
  "docSlug": "65af9093c9ec9ca745928fa125179681",
  "documentTitle": "Avantor | Investor Day Presentation Deck | 89 slides",
  "authorId": "avantor",
  "authorName": "Avantor",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 89,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 7,
  "notes": "The slide uses a mix of financial metrics and growth projections to characterize the Biopharma segment.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-70b9-744d-9fdd-cb0d25e1c298/22",
  "deckHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298",
  "deckJsonHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298.json",
  "deckAnchorHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.45,
        "y": 0.4
      },
      "kind": "image",
      "text": "Three circular images showing lab work, storage, and production",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c98eaf15-7320-47fc-af0e-5060d5066df0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.55,
        "x": 0.42,
        "y": 0.3
      },
      "kind": "list",
      "text": "1. RESEARCH & DEVELOPMENT, 2. CLINICAL & BIOREPOSITORY, 3. BIOPRODUCTION",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b042f277-9a5a-4ba0-b7aa-f2101da29021",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.45,
        "y": 0.65
      },
      "kind": "metric",
      "text": "~55% of Biopharma Revenue, ~10% of Biopharma Revenue, ~35% of Biopharma Revenue",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "258b20ed-8482-406d-ba0e-ef215a7a646d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.18,
        "x": 0.13,
        "y": 0.28
      },
      "kind": "metric",
      "text": "~$3B 2020 AVANTOR SALES 50% OF REVENUE",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7084bdc5-9276-40cb-a1a1-9b78d56f6baa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.06,
        "y": 0.7
      },
      "kind": "metric",
      "text": "$38B TOTAL ADDRESSABLE MARKET (TAM)",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85b68ba1-4880-4628-be52-2c6d0dc671f5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.12,
        "x": 0.26,
        "y": 0.7
      },
      "kind": "metric",
      "text": "+HSD LONG-TERM GROWTH",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f66a3f1b-8085-49fc-8e72-13ca4c82aa48",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.22,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "1. FY20 revenue 2. Market size per company estimates 3. FY21 estimates, excluding pending M&A",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e0689c66-853f-4b1d-8f14-fcdf6e2def71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "By the numbers: Biopharma",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "895f7a6f-0775-4ddf-a22e-23c064ff2ccb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.55,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "Enabling life-altering breakthrough treatments to improve patient outcomes",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62fdb4c3-2e91-4084-8dfd-f3ca95760653",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 89,
      "from": 17,
      "beatId": "2aa3ce3e-d4bb-4cda-b13e-25db1a3054af",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "Growth prospects and financial highlights",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 40,
      "from": 21,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "44a7c149-2da8-4925-9541-064336919963",
      "evidence": "Case study and supporting data",
      "position": 0,
      "objective": "Show how Avantor's offering supports Biopharma R&D activities",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}